NCT04767802View on ClinicalTrials.gov

PTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 2, 2021

Primary Completion Date

March 15, 2023

Study Completion Date

March 15, 2023

Conditions
Polycythemia Vera
Interventions
DRUG

PTG-300

Hepcidin mimetic

Trial Locations (8)

Unknown

Hospital Sultanah Aminah, Johor Bahru

Hospital Raja Perempuan Zainab, Kota Bharu

Hospital Raja Permaisuki Bainun, Ipoh

Hospital Umum Sarawak, Kuching

Hospital Ampang, Ampang

Gachon University Medical Center, Incheon

Seoul National University Hospital, Seoul

Seoul St. Mary's Catholic University Hospital, Seoul

All Listed Sponsors
lead

Protagonist Therapeutics, Inc.

INDUSTRY

NCT04767802 - PTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit | Biotech Hunter | Biotech Hunter